These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11356406)

  • 1. High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy.
    Salomone OA; Caeiro TF; Madoery RJ; Amuchástegui M; Omelinauk M; Juri D; Kaski JC
    Am J Cardiol; 2001 May; 87(10):1217-20; A7. PubMed ID: 11356406
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma norepinephrine in Chagas' cardioneuromyopathy: a marker of progressive dysautonomia.
    Iosa D; DeQuattro V; Lee DD; Elkayam U; Palmero H
    Am Heart J; 1989 Apr; 117(4):882-7. PubMed ID: 2494874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of human brain natriuretic peptide in patients with Chagas' disease].
    Melo RB; Parente GB; Victor EG
    Arq Bras Cardiol; 2005 Feb; 84(2):137-40. PubMed ID: 15761636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid levels in Chagas' disease.
    Abreu MC; Guimarães RC; Krieger H
    Mem Inst Oswaldo Cruz; 1989; 84(2):151-5. PubMed ID: 2517563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients.
    Ferreira RC; Ianni BM; Abel LC; Buck P; Mady C; Kalil J; Cunha-Neto E
    Mem Inst Oswaldo Cruz; 2003 Apr; 98(3):407-11. PubMed ID: 12886425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neopterin in patients with Chagas disease.
    Zerlotti H; Grotto W; Costa FF; Carnéiro MV; Galiza Neto GC
    Trans R Soc Trop Med Hyg; 1994; 88(1):75. PubMed ID: 8154010
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined measurement of N-terminal pro-B-type natriuretic peptide and highly sensitive cardiac troponin T for diagnosis and monitoring of heart injury in chronic Chagas' disease.
    Munoz Saravia SG; Haberland A; Bartel S; Araujo R; Valda G; Reynaga DD; Ramirez ID; Borges AC; Wallukat G; Ziebig R; Schimke I
    Clin Biochem; 2013 Oct; 46(15):1615-8. PubMed ID: 23810852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin levels in different forms of Chagas' disease.
    Fernandes F; Dantas S; Ianni BM; Ramires FJ; Buck P; Salemi VM; Lopes HF; Mady C
    Braz J Med Biol Res; 2007 Dec; 40(12):1631-6. PubMed ID: 17713658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy.
    Mocelin AO; Issa VS; Bacal F; Guimarães GV; Cunha E; Bocchi EA
    Eur J Heart Fail; 2005 Aug; 7(5):869-73. PubMed ID: 16043406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prothrombotic state in early stages of chronic chagas' disease].
    Herrera RN; Díaz E; Pérez R; Chaín S; Sant-Yacumo R; Rodríguez E; Bianchi J; Coviello A; Miotti J; Flores I; de la Serna F; Muntaner J; Berman S; Luciardi H
    Rev Esp Cardiol; 2003 Apr; 56(4):377-82. PubMed ID: 12689572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein deficiency alters CX3CL1 and endothelin-1 in experimental Trypanosoma cruzi-induced cardiomyopathy.
    Martins RF; Martinelli PM; Guedes PM; da Cruz Pádua B; Dos Santos FM; Silva ME; Bahia MT; Talvani A
    Trop Med Int Health; 2013 Apr; 18(4):466-76. PubMed ID: 23398597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi: infectivity and virulence of trypomastigotes incubated with leukocytes and serum from patients with Chagas' disease.
    Mosca W; Briceño L; Velasco J
    Acta Cient Venez; 1992; 43(5):290-4. PubMed ID: 1343741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloproteinases 2 and 9 in different stages of chronic Chagas disease.
    Garcia-Saldivia M; Lopez-Mendez G; Berrueta L; Salmen S; Donis JH; Davila DF
    Int J Cardiol; 2015 Jan; 179():79-81. PubMed ID: 25464419
    [No Abstract]   [Full Text] [Related]  

  • 14. [Basic causes of death in elderly patients with Chagas' disease].
    de Menezes M; Rocha A; da Silva AC; da Silva AM
    Arq Bras Cardiol; 1989 Feb; 52(2):75-8. PubMed ID: 2512897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure].
    López L; Arai K; Giménez E; Jiménez M; Pascuzo C; Rodríguez-Bonfante C; Bonfante-Cabarcas R
    Rev Esp Cardiol; 2006 Jan; 59(1):50-6. PubMed ID: 16434004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease causing cardiac disease in three patients.
    Sartori AM; Shikanai-Yasuda MA; Amato Neto V; Lopes MH
    Clin Infect Dis; 1998 Jan; 26(1):177-9. PubMed ID: 9455528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of positive serology to Trypanosoma cruzi in patients with clinical diagnosis of dilated myocardiopathy in the state of Campeche].
    Alducin-Téllez C; Rueda-Villegas E; Medina-Yerbes I; Hernández O; López R; Peña-Hernández V; Monteón V
    Arch Cardiol Mex; 2011; 81(3):204-7. PubMed ID: 21975234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients.
    Wallukat G; Muñoz Saravia SG; Haberland A; Bartel S; Araujo R; Valda G; Duchen D; Diaz Ramirez I; Borges AC; Schimke I
    J Am Coll Cardiol; 2010 Feb; 55(5):463-8. PubMed ID: 20117461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic Chagas cardiomyopathy. Serologic and anatomopathologic study].
    Sagua H; Neira I; Valdés G; Blanchard J
    Bol Chil Parasitol; 1994; 49(1-2):3-8. PubMed ID: 7632337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADENOSINE DEAMINASE ACTIVITY AND SERUM C-REACTIVE PROTEIN AS PROGNOSTIC MARKERS OF CHAGAS DISEASE SEVERITY.
    Bravo-Tobar ID; Nello-Pérez C; Fernández A; Mogollón N; Pérez MC; Verde J; Concepción JL; Rodriguez-Bonfante C; Bonfante-Cabarcas R
    Rev Inst Med Trop Sao Paulo; 2015; 57(5):385-92. PubMed ID: 26603224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.